Literature DB >> 11693978

Effective screening programmes for cervical cancer in low- and middle-income developing countries.

R Sankaranarayanan1, A M Budukh, R Rajkumar.   

Abstract

Cervical cancer is an important public health problem among adult women in developing countries in South and Central America, sub-Saharan Africa, and south and south-east Asia. Frequently repeated cytology screening programmes--either organized or opportunistic--have led to a large decline in cervical cancer incidence and mortality in developed countries. In contrast, cervical cancer remains largely uncontrolled in high-risk developing countries because of ineffective or no screening. This article briefly reviews the experience from existing screening and research initiatives in developing countries. Substantial costs are involved in providing the infrastructure, manpower, consumables, follow-up and surveillance for both organized and opportunistic screening programmes for cervical cancer. Owing to their limited health care resources, developing countries cannot afford the models of frequently repeated screening of women over a wide age range that are used in developed countries. Many low-income developing countries, including most in sub-Saharan Africa, have neither the resources nor the capacity for their health services to organize and sustain any kind of screening programme. Middle-income developing countries, which currently provide inefficient screening, should reorganize their programmes in the light of experiences from other countries and lessons from their past failures. Middle-income countries intending to organize a new screening programme should start first in a limited geographical area, before considering any expansion. It is also more realistic and effective to target the screening on high-risk women once or twice in their lifetime using a highly sensitive test, with an emphasis on high coverage (>80%) of the targeted population. Efforts to organize an effective screening programme in these developing countries will have to find adequate financial resources, develop the infrastructure, train the needed manpower, and elaborate surveillance mechanisms for screening, investigating, treating, and following up the targeted women. The findings from the large body of research on various screening approaches carried out in developing countries and from the available managerial guidelines should be taken into account when reorganizing existing programmes and when considering new screening initiatives.

Entities:  

Mesh:

Year:  2001        PMID: 11693978      PMCID: PMC2566667     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  165 in total

1.  Double jeopardy: HIV and cervical cancer in Indian women.

Authors:  V Sahasrabuddhe; S Makhija
Journal:  Int J Gynecol Cancer       Date:  2005 Jan-Feb       Impact factor: 3.437

2.  Human papillomavirus vaccine: a boon or curse.

Authors:  Sumit Chawla; Inderjeet Singh; Rambilas Jain; Bharti Mehta; Sneh Kumari; Soumya Swaroop Sahoo
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Comparison of Vaginal versus Oral Estradiol Administration in Improving the Visualization of Transformation Zone (TZ) during Colposcopy.

Authors:  Seema Beniwal; Binni Makkar; Swaraj Batra; Gauri Gandhi; Deepti Goswami; Vijay Zutshi
Journal:  J Clin Diagn Res       Date:  2016-07-01

4.  Perception and risk factors for cervical cancer among women in northern Ghana.

Authors:  Constance A Opoku; Edmund Nii Laryea Browne; Kathryn Spangenberg; Cheryl Moyer; David Kolbilla; Katherine J Gold
Journal:  Ghana Med J       Date:  2016-06

5.  A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa.

Authors:  Hilary K Whitham; Stephen E Hawes; Haitao Chu; J Michael Oakes; Alan R Lifson; Nancy B Kiviat; Papa Salif Sow; Geoffrey S Gottlieb; Selly Ba; Marie P Sy; Shalini L Kulasingam
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-05-17       Impact factor: 4.254

6.  Knowledge and Awareness of HPV Infection and Vaccination Among Urban Adolescents in India: A Cross-Sectional Study.

Authors:  Krishna Kavita Ramavath; Roza Olyai
Journal:  J Obstet Gynaecol India       Date:  2013-06-27

7.  Promoters of and barriers to cervical cancer screening in a rural setting in Tanzania.

Authors:  Powell Perng; Wei Perng; Twalib Ngoma; Crispin Kahesa; Julius Mwaiselage; Sofia D Merajver; Amr S Soliman
Journal:  Int J Gynaecol Obstet       Date:  2013-09-04       Impact factor: 3.561

8.  Knowledge, attitudes, and beliefs of patients with chronic liver disease.

Authors:  Brett Burnham; Sherrie Wallington; Irene A Jillson; Holta Trandafili; Kirti Shetty; Judy Wang; Christopher A Loffredo
Journal:  Am J Health Behav       Date:  2014-09

9.  Structural barriers to screening for and treatment of cervical cancer in Peru.

Authors:  Valerie A Paz-Soldán; Angela M Bayer; Lauren Nussbaum; Lilia Cabrera
Journal:  Reprod Health Matters       Date:  2012-12

10.  Acceptability of HPV vaccine implementation among parents in India.

Authors:  Proma Paul; Amanda E Tanner; Patti E Gravitt; K Vijayaraghavan; Keerti V Shah; Gregory D Zimet; Catch Study Group
Journal:  Health Care Women Int       Date:  2013-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.